Literature DB >> 11727931

The HIF pathway: implications for patterns of gene expression in cancer.

C C Wykoff1, C W Pugh, A L Harris, P H Maxwell, P J Ratcliffe.   

Abstract

Regulation of the growth and metabolism of large organisms is tightly constrained by the need for precise oxygen homeostasis. Work on control of the haematopoietic growth factor erythropoietin has led to the recognition of a widespread transcriptional response to hypoxia which provides insights into how this is achieved. The central mediator of this response is a DNA binding complex termed hypoxia inducible factor 1 (HIF-1), which plays a key role in the regulation by oxygen of a large and rapidly growing panel of genes. In cancer, activity of the HIF system is up-regulated both by microenvironmental hypoxia and by genetic changes. The clearest example of genetic activation is seen in the hereditary cancer syndrome von Hippel-Lindau (VHL) disease. In normal cells the product of the VHL tumour suppressor gene targets the regulatory HIF subunits (HIF-1alpha and HIF-2alpha) for oxygen-dependent proteolysis, acting as the substrate recognition component of an E3 ubiquitin ligase. In pVHL defective cells this process is blocked leading to constitutive up-regulation of HIF-1alpha subunits, activation of the HIF complex and overexpression of HIF target genes. Using gene array screens we have defined a large number of VHL-regulated genes. The majority of these show hypoxia-inducible responses, supporting the central involvement of pVHL in gene regulation by oxygen. In addition to known HIF target genes involved in angiogenesis, glucose metabolism and vasomotor control, these new targets include examples with functions in matrix metabolism, apoptosis, carbon dioxide metabolism and secondary cascades of transcriptional control. Thus activation of HIF provides insights into the classical metabolic alterations in cancer cells, and into the mechanisms by which microenvironmental hypoxia might influence tumour behaviour. In the case of VHL disease, this activation can be linked to mutations in a defined tumour suppressor gene. Equally regulation of the HIF-1alpha/pVHL interaction in normal cells should provide insights into the physiological mechanisms operating in cellular oxygen sensing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727931     DOI: 10.1002/0470868716.ch15

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  16 in total

1.  Effect of hypoxia on the expression of RANKL/OPG in human periodontal ligament cells in vitro.

Authors:  Xi-Jiao Yu; Chang-Jie Xiao; Yan-Mei Du; Shuang Liu; Yi Du; Shu Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Splice isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4: expression and hypoxic regulation.

Authors:  Oleksandr H Minchenko; Tsutomu Ogura; Iryna L Opentanova; Dmytro O Minchenko; Hiroyasu Esumi
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

3.  Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.

Authors:  Alan McIntyre; Shalini Patiar; Simon Wigfield; Ji-Liang Li; Ioanna Ledaki; Helen Turley; Russell Leek; Cameron Snell; Kevin Gatter; William S Sly; Richard D Vaughan-Jones; Pawel Swietach; Adrian L Harris
Journal:  Clin Cancer Res       Date:  2012-04-12       Impact factor: 12.531

4.  Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.

Authors:  Maike Zimmermann; Aruni P S Arachchige-Don; Michaela S Donaldson; Tommaso Patriarchi; Mary C Horne
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

Review 5.  Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

Review 6.  The tumor microenvironment and metastatic disease.

Authors:  Sarah Jane Lunt; Naz Chaudary; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2008-06-10       Impact factor: 5.150

Review 7.  Recent insights on circulating catecholamines in hypertension.

Authors:  Quang V Ton; Stephen R Hammes
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

8.  Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo.

Authors:  Nathaniel H Boyd; Kiera Walker; Joshua Fried; James R Hackney; Paul C McDonald; Gloria A Benavides; Raffaella Spina; Alessandra Audia; Sarah E Scott; Catherine J Landis; Anh Nhat Tran; Mark O Bevensee; Corinne Griguer; Susan Nozell; G Yancey Gillespie; Burt Nabors; Krishna P Bhat; Eli E Bar; Victor Darley-Usmar; Bo Xu; Emily Gordon; Sara J Cooper; Shoukat Dedhar; Anita B Hjelmeland
Journal:  JCI Insight       Date:  2017-12-21

9.  Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance.

Authors:  Janine T Erler; Christopher J Cawthorne; Kaye J Williams; Marianne Koritzinsky; Bradley G Wouters; Clare Wilson; Crispin Miller; Costas Demonacos; Ian J Stratford; Caroline Dive
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Heme Oxygenase-1 Inhibition Potentiates the Effects of Nab-Paclitaxel-Gemcitabine and Modulates the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma.

Authors:  Iman M Ahmad; Alicia J Dafferner; Kelly A O'Connell; Kamiya Mehla; Bradley E Britigan; Michael A Hollingsworth; Maher Y Abdalla
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.